LEADER 00826nam0-2200313---450-
001 990009398050403321
005 20110714143907.0
010   $a978-88-6116-121-4
035   $a000939805
035   $aFED01000939805
035   $a(Aleph)000939805FED01
035   $a000939805
100   $a20110714d2010----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $aa-------001yy
200 1 $aLiving in Berlin$fFederico Ferrari
210   $aMilano$cMotta$d2010
215   $a381 p.$cill.$d19 cm
225 1 $aTools Architecture
610 0 $aBerlino$aarchitettura
700  1$aFerrari,$bFederico$0280877
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009398050403321
952   $aURB.LE B 2359$b18197$fFARBC
959   $aFARBC
996   $aLiving in Berlin$9765253
997   $aUNINA

LEADER 01956nam  2200337   450 
001 9910734348103321
005 20230816092229.0
035   $a(CKB)5470000002907828
035   $a(NjHacI)995470000002907828
035   $a(EXLCZ)995470000002907828
100   $a20230816d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNew Insights into Endometrial Cancer 2022 /$fedited by Laura Paleari
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (178 pages)
311   $a3-0365-7914-1 
330   $aThis open access Special Issue brings together original research and review articles on molecular oncology, with attention given to endometrial cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this Special Issue is that it is a platform for open-source sharing of significant works in the field of molecular oncology that can increase our understanding of endometrial cancer development, which may lead to the discovery of new molecular diagnostic technologies and targeted therapeutics.  Topics include:  Molecular methods to personalize endometrial cancer screening and detection;  Identification and new aspects of cellular signaling molecules and pathways for target discovery, drug design, and personalized and gender medicine;  DDI discovery in endometrial cancer management;  Drug repurposing for endometrial cancer prevention/treatment;  Molecular modeling studies.
606   $aCancer$xResearch
615  0$aCancer$xResearch.
676   $a616.9940072
702   $aPaleari$b Laura
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910734348103321
996   $aNew Insights into Endometrial Cancer 2022$93401555
997   $aUNINA